This Project has two goals: 1. To identify and characterize the single nucleotide polymorphisms (SNPs) that are? found in the human genes which compose the p53 pathway in cells. 2. To expand and utilize the algorithm? we have previously designed to detect the p53 responsive elements (P53 REs, the DNA? sequences that permit a gene to be regulated by p53) and identify the genes regulated by p53 in the mouse? and human genomes. To date we have identified over 1,300 SNPs in 82 genes in the human genome that? function in the p53 network and we are creating a web site to share these data. We have developed? methods to identify which SNPs have the best chance of altering the molecular, cellular and clinical? phenotypes of the p53 pathway. We have focused upon several SNPs (the lead SNPs are in HDM-2, Perp? and AKT), which result in an altered phenotype at the molecular (changed levels and activity), cellular (an? altered frequency of apoptosis) and clinical (a younger age of onset of cancers and increased number of? cancers in humans) levels of analysis. We have characterized 120 EBV-transformed lymphoblastoid cell? lines from normal individuals for their apoptotic index (the percentage of cells that undergo apoptosis after 5? Gy of radiation, a reproducible p53-dependent function) and typed these lines for our SNPs providing? statistically significant correlations for the impact of a SNP. These cell lines will become a resource for the? field that wishes to analyze apoptosis and the p53 pathway. For example SNP 309 in the promoter of the? HDM-2 gene, creates a new SP-1 site, increases the levels of HDM-2 protein in a cell, lowers the p53? transcriptional response, lowers the apoptotic index and reduces the age of onset of cancers in humans by? 12-15 years. We will validate and expand new p53 targets (eg, PTEN, TSC-2, Huntingtin? and LINE-1) and determine when and how they are regulated by p53. Collaborative studies with Prives,? Lowe and Cordon-Cardo are planned to carry out these aims.
| Rastogi, Chaitanya; Rube, H Tomas; Kribelbauer, Judith F et al. (2018) Accurate and sensitive quantification of protein-DNA binding affinity. Proc Natl Acad Sci U S A 115:E3692-E3701 |
| Baugh, Evan H; Ke, Hua; Levine, Arnold J et al. (2018) Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ 25:154-160 |
| Agmon, Eran; Solon, Jérôme; Bassereau, Patricia et al. (2018) Modeling the effects of lipid peroxidation during ferroptosis on membrane properties. Sci Rep 8:5155 |
| Yozwiak, Carrie E; Hirschhorn, Tal; Stockwell, Brent R (2018) Toward a Microparticle-Based System for Pooled Assays of Small Molecules in Cellular Contexts. ACS Chem Biol 13:761-771 |
| Hirschhorn, Tal; Stockwell, Brent R (2018) The development of the concept of ferroptosis. Free Radic Biol Med : |
| Liu, Hengrui; Schreiber, Stuart L; Stockwell, Brent R (2018) Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy. Biochemistry 57:2059-2060 |
| Conrad, Marcus; Kagan, Valerian E; Bayir, Hülya et al. (2018) Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev 32:602-619 |
| Zhang, Yan; Larraufie, Marie-Hélène; Musavi, Leila et al. (2018) Design of Small Molecules That Compete with Nucleotide Binding to an Engineered Oncogenic KRAS Allele. Biochemistry 57:1380-1389 |
| Shimada, Kenichi; Reznik, Eduard; Stokes, Michael E et al. (2018) Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells. Cell Chem Biol 25:585-594.e7 |
| Gaschler, Michael M; Andia, Alexander A; Liu, Hengrui et al. (2018) FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol 14:507-515 |
Showing the most recent 10 out of 159 publications
